UBS AG is offering $470,000 of trigger autocallable contingent Yield notes linked to the Solactive U.S. Large Cap Volatility Navigator index and due September 16, 2031. Investors face an issue price above the notes’ estimated initial value, while any secondary-market price may differ from that estimate.
Key Highlights
- UBS AG will receive $467,180 in proceeds after the offering’s total Underwriting discount.
- The notes mature on September 16, 2031, and pay a contingent coupon only when the index reaches or exceeds the applicable coupon barrier on an observation date.
- Maturity is September 16, 2031.
- The notes pay a contingent coupon only when the index reaches or exceeds the applicable coupon barrier on an observation date.
The notes carry a September 16, 2031 Maturity and pay a contingent coupon only when the index reaches or exceeds the applicable coupon barrier on an observation date.
$470,000 Note Offering Sets Distribution Terms
The public issue price is $470,000 in total, or $1,000 for each note. The aggregate underwriting discount is $2,820, equal to $6 per note, leaving UBS AG with $467,180 in proceeds overall and $994 for each note after that discount.
Estimated Value Falls Below Public Issue Price
The estimated initial value is based on internal pricing models that use the underlying asset’s level and volatility, its embedded decrement, interest rates, the notes’ term and UBS AG’s internal funding rate. A secondary-market price, if available, may differ materially from that estimate.
FAQs
Q: What index underlies UBS AG’s autocallable notes?
A: It states only that coupon payments depend on the index reaching or exceeding the applicable coupon barrier on an observation date.
Q: How much is the UBS AG notes offering worth?
A: The UBS AG notes offering is worth $470,000 in total at the public issue price. That equals $1,000 per note.
Q: What is the UBS AG notes underwriting discount?
A: The total underwriting discount is $2,820, or $6 per note. UBS AG’s proceeds are $467,180 in total, while the stated proceeds are $994 per note.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.